These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35504938)

  • 1. Time-dependent effect of desensitization with wasp venom on selected parameters of the immune system.
    Szymański Ł; Urbańska W; Ciepielak M; Cios A; Stankiewicz W; Stelmasiak M; Rzeszotarska A; Korsak J; Lewicki S; Chciałowski A
    Sci Rep; 2022 May; 12(1):7206. PubMed ID: 35504938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
    Pospischil IM; Kagerer M; Cozzio A; Angelova-Fischer I; Guenova E; Ballmer-Weber B; Hoetzenecker W
    Int Arch Allergy Immunol; 2020; 181(10):783-789. PubMed ID: 32781451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells.
    Pierkes M; Bellinghausen I; Hultsch T; Metz G; Knop J; Saloga J
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):326-32. PubMed ID: 9949326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children.
    Cichocka-Jarosz E; Sanak M; Szczeklik A; Brzyski P; Gielicz A; Pietrzyk JJ
    J Investig Allergol Clin Immunol; 2011; 21(4):260-9. PubMed ID: 21721371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
    Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy.
    Mamessier E; Birnbaum J; Dupuy P; Vervloet D; Magnan A
    Clin Exp Allergy; 2006 Jun; 36(6):704-13. PubMed ID: 16776670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.
    Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Aberer W; Birnbaum J; Bodzenta-Lukaszyk A; Bonifazi F; Bucher C; Campi P; Darsow U; Egger C; Haeberli G; Hawranek T; Kucharewicz I; Küchenhoff H; Lang R; Quercia O; Reider N; Severino M; Sticherling M; Sturm GJ; Wüthrich B;
    J Allergy Clin Immunol; 2010 Jul; 126(1):105-11.e5. PubMed ID: 20542320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
    Rosman Y; Nashef F; Cohen-Engler A; Meir-Shafrir K; Lachover-Roth I; Confino-Cohen R
    Int Arch Allergy Immunol; 2019; 180(2):128-134. PubMed ID: 31216540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes.
    Schuerwegh AJ; De Clerck LS; Bridts CH; Stevens WJ
    Clin Exp Allergy; 2001 May; 31(5):740-6. PubMed ID: 11422133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of specific immunotherapy using an ultra-rush induction regimen in bee and wasp allergy.
    Bożek A; Kołodziejczyk K
    Hum Vaccin Immunother; 2018 Feb; 14(2):288-291. PubMed ID: 29106324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients.
    Wenzel J; Meissner-Kraemer M; Bauer R; Bieber T; Gerdsen R
    Allergy; 2003 Nov; 58(11):1176-9. PubMed ID: 14616130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMMD8 changes expression during initial phase of wasp venom immunotherapy.
    Kempiński K; Romantowski J; Maciejewska A; Pawłowski R; Chełmińska M; Jassem E; Niedoszytko M
    J Gene Med; 2020 Nov; 22(11):e3243. PubMed ID: 32559011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children.
    Cichocka-Jarosz E; Sanak M; Szczeklik A; Brzyski P; Pietrzyk JJ
    Ann Agric Environ Med; 2014; 21(2):294-301. PubMed ID: 24959779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
    Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
    Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
    Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
    Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wasp venom rush immunotherapy induces transient downregulation of B cell surface molecule expression.
    Roever AC; Henz BM; Worm M
    Int Arch Allergy Immunol; 2002 Mar; 127(3):226-33. PubMed ID: 11979048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrarush venom desensitization after systemic reactions during conventional venom immunotherapy.
    Oren E; Chegini S; Hamilos DL
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):606-10. PubMed ID: 17165267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.